Born in Milan in 1981, Federico Mambretti holds a Master’s degree in Political Economy and Economic, Statistical, and Social Sciences from Bocconi University. He earned an MBA from INSEAD and completed specialized courses at Harvard, Wharton, and the London School of Economics. He spent approximately ten years working in pharmaceutical consulting across Europe and the United States with Kearney, ZS, and BCG. Throughout his career, he has lived and worked in ten countries, holding both local and global roles within the innovative and off-patent pharmaceutical sectors. In Italy, he led the Biosimilars Business Unit at Sandoz and the Immunology Franchise at Novartis. Most recently, he served as President and CEO of Novartis in Belgium and Luxembourg, while also sitting on the board of the local industry association, Pharma.be, for five years.
Novartis is among the world leaders in the pharmaceutical sector and has a significant presence in Italy. The headquarters is located in Milan, the beating heart of the Innovative Medicines and Sandoz divisions.
Among the production sites, the one in Torre Annunziata (NA) stands out, a globally important hub for the Group and one of the main ones in Southern Italy. The high technology Novartis has also chosen Piedmont, where Advanced Accelerator Applications is based in the technological park of Ivrea and other research centers, as well as Molise and Emilia-Romagna.
With a wide network across the national territory, Novartis confirms its commitment to Italy: a strategic country for a company that makes innovation its mission.
Unlock trend
The chart shows the evolution over time of the manager's online reputation. The reputation index is represented by a score ranging from 0 to 100.
Unlock trend
The chart shows the evolution over time of the manager's online reputation.
Unlock trend
The chart shows the evolution over time of the online reputation of the managers in the analyzed sector. The average value is calculated based on the top five scores in the sector.